Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of Translational Medicine|January 18, 2024
New advances of the androgen receptor in prostate cancer: report from the 1st International Androgen Receptor SymposiumSherif Mehralivand, Christian Thomas, Martin Puhr, et al.
Life (Basel, Switzerland)|September 28, 2021
A Systematic Comparison of Antiandrogens Identifies Androgen Receptor Protein Stability as an Indicator for Treatment ResponseTiziana Siciliano, Ingo H Simons, Alicia-Marie K Beier, et al.
International Journal of Molecular Sciences|February 15, 2022
Impact of Androgen Receptor Activity on Prostate-Specific Membrane Antigen Expression in Prostate Cancer CellsUlrich Sommer, Tiziana Siciliano, Celina Ebersbach, et al.
Plos One|August 14, 2020
Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancerHolger H H Erb, Julia Bodenbender, Florian Handle, et al.
International Journal of Molecular Sciences|September 14, 2024
Prostate Cancer's Silent Partners: Fibroblasts and Their Influence on Glutamine Metabolism ManipulationPia V Hönscheid, Gustavo B Baretton, Martin Puhr, et al.
Endocrine-Related Cancer|August 6, 2013
IL6 sensitizes prostate cancer to the antiproliferative effect of IFNα2 through IRF9Holger H H Erb, Regina V Langlechner, Patrizia L Moser, et al.
Molecular Cancer Therapeutics|June 29, 2011
Inhibition of the acetyltransferases p300 and CBP reveals a targetable function for p300 in the survival and invasion pathways of prostate cancer cell linesFrédéric R Santer, Philipp P S Höschele, Su Jung Oh, et al.
Molecular Cancer Therapeutics|September 27, 2018
The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate ModelsFlorian Handle, Martin Puhr, Georg Schaefer, et al.
The American Journal of Pathology|August 21, 2024
Inhibition of the Sterol Regulatory Element Binding Protein SREBF-1 Overcomes Docetaxel Resistance in Advanced Prostate CancerMaximilian P Brandt, Olesya Vakhrusheva, Hubert Hackl, et al.
Oncogene|May 15, 2024
Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancerAlicia-Marie K Beier, Celina Ebersbach, Tiziana Siciliano, et al.
Pageof 5